| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-05-11 16:27:34 UTC |
|---|
| Updated at | 2022-05-11 16:27:35 UTC |
|---|
| NP-MRD ID | NP0086666 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Succinyladenosine |
|---|
| Description | Succinyladenosine belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Succinyladenosine is a strong basic compound (based on its pKa). In humans, succinyladenosine is involved in the metabolic disorder called the canavan disease pathway. Succinyladenosine is a potentially toxic compound. Succinyladenosine is found in Penicillium chrysogenum and Zea mays. Succinyladenosine was first documented in 2004 (PMID: 15571235). Succinyladenosine, with regard to humans, has been found to be associated with the diseases such as autism; succinyladenosine has also been linked to several inborn metabolic disorders including fumarase deficiency, adenylosuccinate lyase deficiency, and atic deficiency (PMID: 15902552). |
|---|
| Structure | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N[C@@H](CC(O)=O)C(O)=O)N=CN=C12 InChI=1S/C14H17N5O8/c20-2-6-9(23)10(24)13(27-6)19-4-17-8-11(15-3-16-12(8)19)18-5(14(25)26)1-7(21)22/h3-6,9-10,13,20,23-24H,1-2H2,(H,21,22)(H,25,26)(H,15,16,18)/t5-,6+,9+,10+,13+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (S)-N-(1,2-Dicarboxyethyl)-adenosine | ChEBI | | 6-(1,2-Dicarboxyethylamino)-9-beta-D-ribofuranosylpurine | ChEBI | | N-(9-beta-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartic acid | ChEBI | | N-9-Ribofuranosyl-9H-purin-6-yl-aspartic acid | ChEBI | | Succinoadenosine | ChEBI | | 6-(1,2-Dicarboxyethylamino)-9-b-D-ribofuranosylpurine | Generator | | 6-(1,2-Dicarboxyethylamino)-9-β-D-ribofuranosylpurine | Generator | | N-(9-b-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartate | Generator | | N-(9-b-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartic acid | Generator | | N-(9-beta-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartate | Generator | | N-(9-Β-D-ribofuranosyl-9H-purin-6-yl)-L-aspartate | Generator | | N-(9-Β-D-ribofuranosyl-9H-purin-6-yl)-L-aspartic acid | Generator | | N-9-Ribofuranosyl-9H-purin-6-yl-aspartate | Generator | | 6-(1,2-Dicarboxyethylamino)-9-beta-delta-ribofuranosylpurine | HMDB | | N-(9-beta-delta-Ribofuranosyl-9H-purin-6-yl)-L-aspartate | HMDB | | N-(9-beta-delta-Ribofuranosyl-9H-purin-6-yl)-L-aspartic acid | HMDB |
|
|---|
| Chemical Formula | C14H17N5O8 |
|---|
| Average Mass | 383.3135 Da |
|---|
| Monoisotopic Mass | 383.10771 Da |
|---|
| IUPAC Name | (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid |
|---|
| Traditional Name | atp - adenosine triphosphate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C(N[C@@H](CC(O)=O)C(O)=O)N=CN=C12 |
|---|
| InChI Identifier | InChI=1S/C14H17N5O8/c20-2-6-9(23)10(24)13(27-6)19-4-17-8-11(15-3-16-12(8)19)18-5(14(25)26)1-7(21)22/h3-6,9-10,13,20,23-24H,1-2H2,(H,21,22)(H,25,26)(H,15,16,18)/t5-,6+,9+,10+,13+/m0/s1 |
|---|
| InChI Key | VKGZCEJTCKHMRL-VWJPMABRSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Nucleosides, nucleotides, and analogues |
|---|
| Class | Purine nucleosides |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Purine nucleosides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Purine nucleoside
- Aspartic acid or derivatives
- Glycosyl compound
- N-glycosyl compound
- 6-alkylaminopurine
- 6-aminopurine
- Alpha-amino acid or derivatives
- Pentose monosaccharide
- L-alpha-amino acid
- Imidazopyrimidine
- Purine
- Aminopyrimidine
- Secondary aliphatic/aromatic amine
- N-substituted imidazole
- Monosaccharide
- Pyrimidine
- Dicarboxylic acid or derivatives
- Imidolactam
- Heteroaromatic compound
- Imidazole
- Tetrahydrofuran
- Azole
- Amino acid or derivatives
- Secondary alcohol
- Amino acid
- Carboxylic acid derivative
- Carboxylic acid
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Organic oxygen compound
- Alcohol
- Organic nitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Amine
- Organopnictogen compound
- Organic oxide
- Primary alcohol
- Organooxygen compound
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|